Therapeutic Efficacy and Safety of Methotrexate in Moderate-to-Severe Atopic Dermatitis: A Retrospective Study of Korean Patients at Tertiary Referral Hospital.

Ji Hong Lee Sook-Jung Yun Jee-Bum Lee Seung-Chul Lee

Published in: Annals of dermatology (2020)

Our results reveal that MTX is a relatively safe drug to control moderate-to-severe AD with satisfactory therapeutic efficacy and inhibitory activity against AD flares.

Keyphrases

atopic dermatitis
high intensity
early onset
drug induced
healthcare
adverse drug
high dose
genome wide
emergency department
gene expression
acute care
low dose